1. The Income from operations of Gujarat Themis Biosyn Limited (A BIRF Company) is as per the plan envisaged by the Management of the Company utilizing capacity to the fullest extent. 2. The Income from operations during the year ended 31st March, 2015 stood at Rs.3144.02 lakhs as compared to Rs. 3023.03 lakhs during the year ended 31st March, 2014. 3. Net Profit improved to Rs. 459.41 lakhs during the period under consideration compared to Rs. 452.60 lakhs during the […]
The Board of Directors of the Company at its meeting held on 28th May, 2015, discussed and approved the following matters: 1. Appointment of Mr. Siddharth Y. Kusumgar (DIN 01676799) as an Additional Independent Director & also inducted him as a member of Audit Committee. 2. Audited Financial Results for the quarter and year ended 31st March, 2015. The Audit Committee of the Company earlier had also reviewed the aforesaid accounts. 3. Formulated and adopted ‘Code of Practices and Procedures […]
The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 25th March, 2015 approved the following. 1. Dr. Vikram D. Sanghvi has been appointed an Independent Director on the Board of the Company w.e.f. 25th March, 2015. 2. Mr. Hinesh Doshi has been appointed as an Alternate Director to Mr. J. H. Choi with immediate effect. 3. Appointment of whole time Practicing Secretary Mr. Manish R Desai as Secretarial Auditor for conducting Secretarial Audit for the […]
The Board of Directors of the Company at its meeting held on 17th March, 2015, discussed and approved the following matters 1. Resignation of Mr. Hinesh Doshi as Alternate Director to Mr. S.S. Lee has been accepted with immediate effect. 2. Mr.Bharat A. Desai has been appointed as Chief Financial Officer (CFO) of the Company w.e.f. 17th March, 2015.
The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 6th February, 2015 approved the following. 1. Unaudited Financial Results for the quarter ended 31st December, 2014. i. The income from operations of Gujarat Themis Biosyn Limited (A BIFR referred Company) is as per the plans envisaged by the Management utilizing capacity to the fullest extent. ii. Income from operations recorded Rs. 2339.13 Lacs during the current nine months ended December, 2014 as against Rs. 2294.10 […]
The Unaudited Financial Results for the Quarter & Half year ended 30th September, 2014 approved by the Board of Directors on 4-11-2014. 1. Income from operations recorded Rs. 1549.68 Lacs during the current Six months ended September, 2014 as against Rs. 1564.29 lacs during the corresponding period of the last year. 2. Net profit increase to Rs. 237.35 lacs during the current Six months as against Rs.206.74 lacs during the corresponding period of the previous year.
The Board of Directors of Gujarat Themis Biosyn Ltd. at it’s meeting held on 6th August, 2014 considered and approved the following: 1. Unaudited Financial Results for the quarter ended 30th June, 2014 2. Mr. A.B Shah’s resignation as nominee director of GIIC Ltd. was accepted by the Board. 3. Mr. Rajneesh Anand, President & CEO of the Company stepped down with effect from 7th August, 2014. His services will however be available to the Company as a Consultant from […]
In order to comply with BIFR order dated 20th November, 2013 as well as SEBI order dated 28th March, 2014 to increase the public shareholding from 15.21% to 25% by 19th August, 2014. One of the promoters, M/s. Pharmaceutical Business Group (India) Ltd has offered for sale of 14,23,000 equity shares (approximately 9.79%) of the face value of Rs.5 each, by way of an offer for sale through the Stock Exchange mechanism and the sale shall take place on August […]
BIFR referred Gujarat Themis Biosyn Ltd., has significantly surpassed the profitability projections as per scheme of Rehabilitation. Net Profit for the year ended 31st March, 2014 was Rs. 452.60 lakhs as against net profit of Rs. 106.98 lakhs for the year ended 31st March, 2013. The negative Net worth of the Company has come down to Rs.534 lakhs as on 31st March 2014 as against Rs. 987 lakhs on 31st March 2013. EPS for the current year stood at Rs. […]
In line with order passed by BIFR on 20th November, 2013 and 2nd January 2014, SEBI passed an order dated 28th March, 2014 allowing the Company to extend the time to comply with minimum public shareholding on or before 19th August, 2014. Also the Company allowed to increase in equity shares from 14,71,250 to 18,96,500 of Rs. 5/- each fully paid up, through public offer or private offer or through any other mode as well as at price as permitted […]